These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 32567731)
1. Tensin4 (TNS4) is upregulated by Wnt signalling in adenomas in multiple intestinal neoplasia (Min) mice. Raposo TP; Alfahed A; Nateri AS; Ilyas M Int J Exp Pathol; 2020 Jun; 101(3-4):80-86. PubMed ID: 32567731 [TBL] [Abstract][Full Text] [Related]
2. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
3. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations. Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937 [TBL] [Abstract][Full Text] [Related]
4. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways. Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ Int J Exp Pathol; 2009 Oct; 90(5):558-74. PubMed ID: 19765110 [TBL] [Abstract][Full Text] [Related]
5. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112 [TBL] [Abstract][Full Text] [Related]
6. BCL9-2 promotes early stages of intestinal tumor progression. Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997 [TBL] [Abstract][Full Text] [Related]
7. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine. Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351 [TBL] [Abstract][Full Text] [Related]
8. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin. Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830 [TBL] [Abstract][Full Text] [Related]
9. Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models. Mieszczanek J; van Tienen LM; Ibrahim AEK; Winton DJ; Bienz M Nat Commun; 2019 Feb; 10(1):724. PubMed ID: 30760710 [TBL] [Abstract][Full Text] [Related]
10. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
17. The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signalling. Chen HZ; Liu QF; Li L; Wang WJ; Yao LM; Yang M; Liu B; Chen W; Zhan YY; Zhang MQ; Cai JC; Zheng ZH; Lin SC; Li BA; Wu Q Gut; 2012 May; 61(5):714-24. PubMed ID: 21873734 [TBL] [Abstract][Full Text] [Related]
18. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis. Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247 [TBL] [Abstract][Full Text] [Related]
19. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis. Kress E; Skah S; Sirakov M; Nadjar J; Gadot N; Scoazec JY; Samarut J; Plateroti M Gastroenterology; 2010 May; 138(5):1863-74. PubMed ID: 20114049 [TBL] [Abstract][Full Text] [Related]
20. Cancer stemness in Apc- vs. Apc/KRAS-driven intestinal tumorigenesis. Ghazvini M; Sonneveld P; Kremer A; Franken P; Sacchetti A; Atlasi Y; Roth S; Joosten R; Smits R; Fodde R PLoS One; 2013; 8(9):e73872. PubMed ID: 24069241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]